HSV-1 based gene therapy(EG 427)

N/A

Report date: 2024/09/19 13:54:05

Base Information

Drug NameHSV-1 based gene therapy(EG 427)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Herpes simplex virus vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder, Neurogenic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEG 427 Inc
China Registration ClassN/A

Develop Information

Active CompaniesEG 427 Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder, Neurogenic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A